The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: Cost-effective high-throughput detection by real-time PCR

Clinica Chimica Acta

Volumn 406, Issue 1-2, 2009, Pages 27-30

  Živković, Maja ^a   Stanković, Aleksandra ^a   Dinčić, Evica ^b   Popović, Milan ^a   Popović, Smiljana ^b   Raičević, Ranko ^b   Alavantić, Dragan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Gene polymorphism; HLA DRB1*1501; Multiple sclerosis; rs3135388

Indexed keywords

GENOMIC DNA; HLA DR ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA ISOLATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SERBIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; COSTS AND COST ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TAQ POLYMERASE; TIME FACTORS;

EID: 67650327397     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.05.004     Document Type: Article

References (23)

1. Lincoln M.R., Montpetit A., Cader M.Z., et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 37 (2005) 1108-1112
2. Allcock R.J., Atrazhev A.M., Beck S., et al. The MHC haplotype project: a resource for HLA-linked association studies. Tissue Antigens 59 (2002) 520-521
3. Horton R., Wilming L., Rand V., et al. Gene map of the extended human MHC. Nat Rev Genet 5 (2004) 889-899
4. Stewart C.A., Horton R., Allcock R.J., et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res 14 (2004) 1176-1187
5. Yeo T.W., De Jager P.L., Gregory S.G., et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol 61 (2007) 228-236
6. de Bakker P.I., McVean G., Sabeti P.C., et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 38 (2006) 1166-1172
7. Hafler D.A., Compston A., Sawcer S., et al. Risk alleles for multiple sclerosis identified by a genome wide study. N Engl J Med 357 (2007) 851-862
8. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
9. Lublin F.D., and Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of New Agents in Multiple Sclerosis. Neurology 46 (1996) 907-911
10. Roxburgh R.H., Seaman S.R., Masterman T., et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64 (2005) 1144-1151
11. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
12. Schmidt H., Williamson D., and Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol 165 (2007) 1097-1109
13. Goris A., Walton A., Ban M., Dubois B., Compston A., and Sawcer S. A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLA-DRB1*1501 allele. Tissue Antigens 72 (2008) 401-403
14. Walsh E.C., Guschwan-McMahon S., Daly M.J., Hafler D.A., and Rioux J.D. Genetic analysis of multiple sclerosis. J Autoimmun 21 (2003) 111-116
15. Boiko A.N., Gusev E.I., Sudomoina M.A., et al. Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology 58 (2002) 658-660
16. Barcellos L.F., Sawcer S., Ramsay P.P., et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 15 (2006) 2813-2824
17. Harbo H.F., Lie B.A., Sawcer S., et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63 (2004) 237-247
18. de Bakker P.I., Burtt N.P., Graham R.R., et al. Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet 38 (2006) 1298-1303
19. Middleton D., Menchaca L., Rood H., and Komerofsky R. New allele frequency database. http://www.allelefrequencies.net. Tissue Antigens 61 (2003) 403-407
20. Ciusani E., Allen M., Sandberg-Wollheim M., et al. Analysis of HLA-class II DQA1, DQB1, DRB1 and DPB1 in Italian multiple sclerosis patients. Eur J Immunogenet 22 (1995) 171-178
21. Allcock R.J., de la Concha E.G., Fernandez-Arquero M., et al. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum Immunol 60 (1999) 1266-1273
22. Ghabanbasani M.Z., Gu X.X., Spaepen M., et al. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DRbeta 1 chain in multiple sclerosis. J Neuroimmunol 59 (1995) 77-82
23. Dean G., Yeo T.W., Goris A., et al. HLA-DRB1 and multiple sclerosis in Malta. Neurology 70 (2008) 101-105